Biosoft Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
- Revenue Growth 80.81%
- Profit Growth -64.50%
- Ebitda -63.23%
- Net Worth 12.47%
- Total Assets 48.06%
About Biosoft Lifesciences
Biosoft Lifesciences Private Limited (BLPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 November 2017 (Seven years and two months 26 days old ). Its registered office is in Sirmaur, Himachal Pradesh, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M.
Surender Kumar and Vansh Rana serve as directors at the Company.
Company Details
-
Location
Sirmaur, Himachal Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999HP2017PTC006782
-
Company No.
006782
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Nov 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
What products or services does Biosoft Lifesciences Private Limited offer?
Biosoft Lifesciences Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Antipyretic Medication, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Diclofenac, Mineral Supplement, Sexual Wellness Products, Fertility Enhancer, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Biosoft Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surender Kumar
|
Director | 16-Nov-2017 | Current |
|
Vansh Rana
|
Director | 26-Feb-2022 | Current |
Financial Performance of Biosoft Lifesciences.
Biosoft Lifesciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 80.81% increase. The company also saw a substantial fall in profitability, with a 64.5% decrease in profit. The company's net worth Soared by an impressive increase of 12.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biosoft Lifesciences?
Unlock access to Biosoft Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Biosun Discovery Private LimitedSurender Kumar and Vansh Rana are mutual person
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 May 2023 | Canara Bank | ₹2.00 M | Open |
How Many Employees Work at Biosoft Lifesciences?
Unlock and access historical data on people associated with Biosoft Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biosoft Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biosoft Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
